Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California
- PMID: 33818615
- PMCID: PMC8022258
- DOI: 10.1001/jamainternmed.2021.0488
Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California
Erratum in
-
Error in Email Address.JAMA Intern Med. 2021 Dec 1;181(12):1679. doi: 10.1001/jamainternmed.2021.6248. JAMA Intern Med. 2021. PMID: 34661598 Free PMC article. No abstract available.
Abstract
This cohort study examines the 30-day incidence of outpatient and hospital-associated venous thromboembolism following SARS-CoV-2 testing among adults in a large health system.
Conflict of interest statement
Comment in
-
Risk of venous thromboembolism in COVID-19 infection.Intern Med J. 2023 Aug;53(8):1478-1480. doi: 10.1111/imj.16145. Epub 2023 Jul 14. Intern Med J. 2023. PMID: 37449583
References
-
- Packard A, Delate T, Martinez K, Clark NP. Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service. Thromb Res. 2020;193:40-44. doi: 10.1016/j.thromres.2020.05.036 - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
